[1] |
OLSON JC. Acute-on-chronic and decompensated chronic liver failure: definitions, epidemiology, and prognostication[J]. Crit Care Clin, 2016, 32(3):301-309. DOI: 10.1016/j.ccc.2016.02.001.
|
[2] |
SARIN SK, CHOUDHURY A. Management of acute-on-chronic liver failure: an algorithmic approach[J]. Hepatol Int, 2018, 12(5):402-416. DOI: 10.1007/s12072-018-9887-5.
|
[3] |
SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update[J]. Hepatol Int, 2019, 13(4):353-390. DOI: 10.1007/s12072-019-09946-3.
|
[4] |
BAJAJ JS. Hepatic encephalopathy: classification and treatment[J]. J Hepatol, 2018, 68(4):838-839. DOI: 10.1016/j.jhep.2017.11.005.
|
[5] |
DURAND F, GRAUPERA I, GINÈS P, et al. Pathogenesis of hepatorenal syndrome: implications for therapy[J]. Am J Kidney Dis, 2016, 67(2):318-328. DOI: 10.1053/j.ajkd.2015.09.013.
|
[6] |
CAI J, ZHANG M, HAN T, et al. Characteristics of infection and its impact on short-term outcome in patients with acute-on-chronic liver failure[J]. Medicine (Baltimore), 2017, 96(37):e8057. DOI: 10.1097/MD.0000000000008057.
|
[7] |
JADLOWIEC CC, TANER T. Liver transplantation: current status and challenges[J]. World J Gastroenterol, 2016, 22(18):4438-4445. DOI: 10.3748/wjg.v22.i18.4438.
|
[8] |
DURAND F. How to improve long-term outcome after liver transplantation?[J]. Liver Int, 2018, 38(Suppl 1):134-138. DOI: 10.1111/liv.13651.
|
[9] |
RAO HB, PRAKASH A, SUDHINDRAN S, et al. Biliary strictures complicating living donor liver transplantation: problems, novel insights and solutions[J]. World J Gastroenterol, 2018, 24(19):2061-2072. DOI: 10.3748/wjg.v24.i19.2061.
|
[10] |
REUBEN A, TILLMAN H, FONTANA RJ, et al. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study[J]. Ann Intern Med, 2016, 164(11):724-732. DOI: 10.7326/M15-2211.
|
[11] |
MU J, CHEN Q, ZHU L, et al. Influence of gut microbiota and intestinal barrier on enterogenic infection after liver transplantation[J]. Curr Med Res Opin, 2019, 35(2):241-248. DOI: 10.1080/03007995.2018.1470085.
|
[12] |
谈宜斌, 金学兰, 李源, 等.肝移植术后医院感染流行病学分析[J].中华器官移植杂志, 2018, 39(10):592-596. DOI: 10.3760/cma.j.issn.0254-1785.2018.10.004.TAN YB, JIN XL, LI Y, et al. Epidemiological study on nosocomial infection after liver transplantation[J]. Chin J Organ Transplant, 2018, 39(10):592-596. DOI: 10.3760/cma.j.issn.0254-1785.2018.10.004.
|
[13] |
OLIVEIRA RA, TURRINI RNT, POVEDA VB. Risk factors for development of surgical site infections among liver transplantation recipients: an integrative literature review[J]. Am J Infect Control, 2018, 46(1):88-93. DOI: 10.1016/j.ajic.2017.05.021.
|
[14] |
DHANASEKARAN R. Management of immunosuppression in liver transplantation[J]. Clin Liver Dis, 2017, 21(2):337-353. DOI: 10.1016/j.cld.2016.12.007.
|
[15] |
BERNAL W, HYYRYLAINEN A, GERA A, et al. Lessons from look-back in acute liver failure? a single centre experience of 3 300 patients[J]. J Hepatol, 2013, 59(1):74-80. DOI: 10.1016/j.jhep.2013.02.010.
|
[16] |
NADIM MK, GENYK YS, TOKIN C, et al. Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome[J]. Liver Transpl, 2012, 18(5):539-548. DOI: 10.1002/lt.23384.
|
[17] |
RUIZ R, BARRI YM, JENNINGS LW, et al. Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT)[J]. Liver Transpl, 2007, 13(6):838-843. doi: 10.1002/lt.21149
|
[18] |
林潮双, 崇雨田, 杨林, 等.原位肝移植术前感染对预后的影响[J].中华医院感染学杂志, 2007, 17(10):1238-1239, 1291. DOI: 10.3321/j.issn:1005-4529.2007.10.019.LIN CS, CHONG YT, YANG L, et al. Impact of infection before orthotopic liver transplantation on prognosis[J]. Chin J Nosocomiol, 2007, 17(10):1238-1239, 1291. DOI: 10.3321/j.issn:1005-4529.2007.10.019.
|
[19] |
NACIF LS, PINHEIRO RS, ROCHA-SANTOS V, et al. Better selection criteria with prognostic factors for liver transplantation[J]. Transplant Proc, 2018, 50(3):766-768. DOI: 10.1016/j.transproceed.2018.02.057.
|
[20] |
SACLEUX SC, SAMUEL D. A critical review of MELD as a reliable tool for transplant prioritization[J]. Semin Liver Dis, 2019, 39(4):403-413. DOI: 10.1055/s-0039-1688750.
|
[21] |
张茜, 侯梅华.血清CysC与hs-CRP对晚期肝硬化肝肾综合征患者的预测价值[J].肝脏, 2019, 24(8):959-961. DOI: 10.3969/j.issn.1008-1704.2019.08.041.ZHANG Q, HOU MH. Prediction value of serum CysC and hs-CRP in patients with liver and kidney syndrome in advanced cirrhosis[J]. Chin Hepatol, 2019, 24(8):959-961. DOI: 10.3969/j.issn.1008-1704.2019.08.041.
|
[22] |
MAWATARI S, MORIUCHI A, OHBA F, et al. The recovery of the PT-INR to less than 1.3 predicts survival in patients with severe acute liver injury[J]. J Gastroenterol, 2018, 53(7):861-872. DOI: 10.1007/s00535-017-1421-3.
|
[23] |
贾亚男, 李瀚, 李先亮, 等.危重症肝病肝移植患者诊断和评估标准的临床进展[J].器官移植, 2020, 11(3): 326-331, 368. DOI: 10.3969/j.issn.1674-7445.2020.03.002.JIA YN, LI H, LI XL, et al. Clinical progress of diagnostic and evaluation criteria for liver transplantation in patients with severe liver disease[J]. Organ Transplant, 2020, 11(3): 326-331, 368. DOI: 10.3969/j.issn.1674-7445.2020.03.002.
|
[24] |
姚运海, 甘建和, 赵卫峰.4种评分系统对肝硬化合并感染患者预后的评估价值[J].临床肝胆病杂志, 2019, 35(1):87-91. DOI: 10.3969/j.issn.1001-5256.2019.01.016.YAO YH, GAN JH, ZHAO WF. Value of four scoring systems in evaluating the prognosis of cirrhotic patients with infection[J]. J Clin Hepatol, 2019, 35(1):87-91. DOI: 10.3969/j.issn.1001-5256.2019.01.016.
|